Publication Name	World Journal of Gastroenterology
Manuscript ID	15282
Country	South Korea

Received	2014-11-19 08:19
Peer-Review Started	2014-11-19 09:14
First Decision by Editorial Office Director
Return for Revision	2014-12-24 10:14
Revised	2015-01-02 10:00
Publication Fee Transferred
Second Decision by Editor	2015-02-10 21:24
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2015-02-11 15:43
Articles in Press	2015-02-11 16:18
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-04-27 09:53
Publish the Manuscript Online	2015-05-18 17:02

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication
Manuscript Source	Unsolicited Manuscript
All Author List	Jae Jin Hwang, Dong Ho Lee, Ae-Ra Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park and Nayoung Kim
Funding Agency and Grant Number
Corresponding Author	Dong Ho Lee, MD, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173 beon-gil, Bundang-gu, Seongnam, Gyeonggi-do 463-707, South Korea. dhljohn@yahoo.co.kr
Key Words	Helicobacter pylori; Treatment failure; Second-line treatment; Moxifloxacin; Eradication rate
Core Tip	This study aimed to evaluate the efficacy of the 14-d moxifloxacin-based triple therapy compared to the corresponding 7-d regimen for second-line Helicobacter pylori (H. pylori) eradication in South Korea. The H. pylori-eradication rates in the RAM-14 group were significantly higher compared to the RAM-7 group for both the intention-to-treat and per-protocol analysis. The high eradication rate, excellent compliance, and safety of the 14-d regimen suggest its potential suitability as an alternative to the standard bismuth-based quadruple therapy. The 14-d moxifloxacin-based triple therapy is a significantly more effective second-line eradication treatment than the 7-d alternative for H. pylori infection in Korean patients.
Publish Date	2015-05-18 17:02
Citation	Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication. World J Gastroenterol 2015; 21(18): 5568-5574
URL	http://www.wjgnet.com/1007-9327/full/v21/i18/5568.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i18.5568

Full Article (PDF)	WJG-21-5568.pdf
Full Article (Word)	WJG-21-5568.doc
Manuscript File	15282-Review.docx
Answering Reviewers	15282-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	15282-Conflict-of-interest statement.pdf
Copyright License Agreement	15282-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	15282-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	15282-Language certificate.pdf
Peer-review Report	15282-Peer-review(s).pdf
Scientific Misconduct Check	15282-Scientific misconduct check.pdf
Scientific Editor Work List	15282-Scientific editor work list.pdf